Walleye Capital
GNOM icon

Walleye Capital’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Walleye Capital’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,121
Closed -$168K – 5153
2023
Q3 		$168K Buy
+4,121
New +$188K ﹤0.01% 3675

Other funds holding GNOM

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $236M AUM 12.89% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Walleye Capital's GNOM Position: Q4 2023 in Review

Walleye Capital sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2023, closing a stake of 4,121 shares — an estimated $168K sold.

Walleye Capital first reported a position in GNOM in Q3 2023 and held it in 1 quarter. The position peaked at $168K in Q3 2023. 61 funds tracked by Wall St. Rank hold GNOM as of Q4 2023.

  • Walleye Capital reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 4,121 Global X Genomics & Biotechnology ETF shares in Q4 2023, an estimated $168K.
  • Walleye Capital first reported a position in Global X Genomics & Biotechnology ETF in Q3 2023 and held it in 1 quarter.
  • Walleye Capital's Global X Genomics & Biotechnology ETF position peaked at $168K in Q3 2023.
  • 61 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.